Omeros , Nasdaq: OMER
Developing drugs for the treatment of surgery-related inflammation and pain.
Industry: Health Care
First Day Return: -12.7%
Industry: Health Care
| IPO Data | |
|---|---|
| IPO File Date | 01/09/2008 |
| Offer Price | $10.00 |
| Price Range $10.00 - $12.00 | |
| Offer Shares (mm) | 6.8 |
| Deal Size ($mm) | $68 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 10/07/2009 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $68 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Seattle, WA, United States |
| Founded | 1994 |
| Employees at IPO | 62 |
| Website www.omeros.com | |
- Omeros quiet period ends November 16 11/11/09
- Verisk is this week's IPO winner 10/09/09
- Mistras Group and Omeros are today's IPOs 10/08/09
Omeros (OMER) Performance
